UNIVERSITY OF NEW MEXICO

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1889-01-01
Employees
6.7K
Market Cap
-
Website
https://www.unm.edu/
Clinical Trials
Related News

Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

Phase 2
Completed
Conditions
Corpus Uteri
Endometrial Cancer
First Posted Date
2005-11-07
Last Posted Date
2010-01-07
Lead Sponsor
University of New Mexico
Target Recruit Count
39
Registration Number
NCT00249990
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico, Albuquerque, New Mexico, United States

Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan

Phase 1
Completed
Conditions
Solid Tumors
Cancer
First Posted Date
2005-11-07
Last Posted Date
2010-01-07
Lead Sponsor
University of New Mexico
Target Recruit Count
21
Registration Number
NCT00249977
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico, Albuquerque, New Mexico, United States

Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)

First Posted Date
2005-11-07
Last Posted Date
2023-12-14
Lead Sponsor
University of New Mexico
Registration Number
NCT00250016
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico, Albuquerque, New Mexico, United States

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Not Applicable
Terminated
Conditions
Cervix
Cancer
First Posted Date
2005-11-07
Last Posted Date
2024-03-12
Lead Sponsor
University of New Mexico
Target Recruit Count
100
Registration Number
NCT00250055
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico, Albuquerque, New Mexico, United States

Immune Dysfunction in Allergic Asthma

Not Applicable
Completed
Conditions
Asthma
Interventions
Drug: Xolair
First Posted Date
2005-09-16
Last Posted Date
2019-09-27
Lead Sponsor
University of New Mexico
Target Recruit Count
18
Registration Number
NCT00189228
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UNM HSC, Albuquerque, New Mexico, United States

Immune Dysregulation in Children and Adults With Asthma

Not Applicable
Completed
Conditions
Asthma
Lung Diseases
First Posted Date
2005-08-26
Last Posted Date
2016-01-15
Lead Sponsor
University of New Mexico
Registration Number
NCT00135681

Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome

Phase 2
Completed
Conditions
Hantavirus Infections
Interventions
Drug: Placebo
Drug: Methylprednisolone
First Posted Date
2005-08-09
Last Posted Date
2014-12-24
Lead Sponsor
University of New Mexico
Target Recruit Count
66
Registration Number
NCT00128180
Locations
๐Ÿ‡จ๐Ÿ‡ฑ

Facultad de Medicina Clinica Alemana- Universidad del Desarrollo, Santiago, Chile

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Phase 1
Completed
Conditions
Kidney Cancer
First Posted Date
2004-07-22
Last Posted Date
2013-12-10
Lead Sponsor
University of New Mexico
Target Recruit Count
35
Registration Number
NCT00003585
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico Cancer Research & Treatment Center, Albuquerque, New Mexico, United States

Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

Phase 2
Completed
Conditions
Kidney Cancer
First Posted Date
2004-06-09
Last Posted Date
2016-05-12
Lead Sponsor
University of New Mexico
Target Recruit Count
35
Registration Number
NCT00003584
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico Cancer Research & Treatment Center, Albuquerque, New Mexico, United States

Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

First Posted Date
2004-05-26
Last Posted Date
2014-05-21
Lead Sponsor
University of New Mexico
Target Recruit Count
18
Registration Number
NCT00002721
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of New Mexico Cancer Research & Treatment Center, Albuquerque, New Mexico, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy